API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-cut-price-its-most-prescribed-insulin-by-78-us-2023-03-16/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021629
https://www.fiercepharma.com/marketing/sanofi-launches-diabetes-campaign-to-advance-personalized-patient-approach
http://www.fiercedrugdelivery.com/story/fda-requires-new-labeling-insulin-pens-ward-spread-infections/2015-03-03
http://www.fiercepharma.com/story/its-put-or-shut-time-sanofi-and-mannkind-afrezza-hits-market/2015-02-03